Myocardial infarction standard treatment group:none

2 trials

Sponsors

Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University

Conditions

Coronary atherosclerotic heart disease

Phase 4

Protective effect of Shenxiang Suhe Pill on myocardial ischemia-reperfusion injury and its mechanism

RecruitingChiCTR2200055170

Sir Run Run Shaw Hospital, College of Medicine, Zhejiang UniversityCoronary atherosclerotic heart disease

Start: 2022-01-01Updated: 2023-01-16

Protective effect of Shenxiang Suhe Pill on myocardial ischemia-reperfusion injury and the related mechanism

Active, not recruitingITMCTR2200005484

Sir Run Run Shaw Hospital, College of Medicine, Zhejiang UniversityCoronary atherosclerotic heart disease

Start: 2022-01-01Updated: 2023-02-20